An Implantable Cardioverter Defibrillator (ICD) is a sophisticated medical device designed to monitor and regulate heart rhythm in individuals at risk of life-threatening arrhythmias. Implanted beneath the skin, typically near the collarbone, the ICD continuously monitors the heart's electrical activity. In the event of a dangerous arrhythmia, the device delivers precisely timed electrical shocks to restore a normal heart rhythm. This crucial intervention can be lifesaving for individuals with conditions such as ventricular tachycardia or ventricular fibrillation. Additionally, modern ICDs often incorporate pacemaker functionality, further assisting in maintaining a steady heart rate. The ICD's capability to provide both defibrillation and pacing makes it a versatile and vital tool in the management of certain cardiac conditions, enhancing the overall quality of life for those at risk of severe arrhythmias.
Title : Fats of Life, the skinny on statins and beyond !
Ahdy Wadie Helmy, Indiana University School of Medicine, United States
Title : Pharmacological advancement in pulmonary arterial hypertension treatment - Contribution of treprostinil dry-powder formulation
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Personalized and Precision Medicine (PPM) and PPN-guided cardiology practice as a unique model via translational applications and upgraded business modeling to secure human healthcare, wellness and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Cardiovascular nanomedicine: Stopping strokes, unclogging arteries and restoring heart function
Thomas J Webster, Hebei University of Technology, China
Title : Antibodies with functionality as a new generation of translational tools designed to monitor autoimmune myocarditis at clinical and subclinical stages
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Perception of cardiovascular risk in women after a rehabilitation program
Maria Teresa Carvallo Marin, Privado, Chile